U.S. Insurance Stock News

Dell Technologies recently announced a partnership with Nvidia and Elastic to enhance its AI Data Platform, leveraging Elastic's Elasticsearch technology alongside Nvidia GPUs on Dell PowerEdge servers to speed up AI workload processing and data search across industries such as media, entertainment, and finance. This collaboration highlights Elastic's expanding footprint in enterprise AI solutions and follows the release of Elastic's Logs Essentials and AI SOC Engine, which introduce new...

Gibraltar Industries recently announced its second-quarter 2025 results, reporting increased sales of US$309.52 million but a decrease in net income to US$26 million compared to the previous year, along with updated full-year guidance projecting lower earnings per share for 2025. While sales growth continued, the company's forecast for reduced annual earnings per share compared to 2024 signals shifting profitability dynamics that may influence expectations for the rest of the year. We'll now...

Earlier this week, Philip Morris International reported continued progress in its transition to smoke-free products, highlighting notable gains in its reduced-risk portfolio and strong pricing power across key markets. A central insight is that the company's smoke-free transformation and cost-saving initiatives are supporting its long-term ambition to decrease reliance on combustibles and enhance profitability. We'll explore how the recent momentum in Philip Morris International's smoke-free...

Arrowhead Pharmaceuticals announced its third quarter and nine-month results for the period ended June 30, 2025, reporting US$27.77 million in quarterly sales and a net loss of US$175.24 million for the quarter, but a shift to net income of US$22.12 million for the nine months, compared to a loss of US$428.96 million a year earlier. This turnaround was driven by a very large year-on-year increase in year-to-date sales, resulting in the company returning to profitability over the nine-month...

Earlier in August 2025, Exact Sciences Corporation reported second-quarter sales of US$811.09 million and a net loss of US$1.19 million, while also raising its full-year 2025 revenue guidance to a range of US$3.13 billion to US$3.17 billion. This update highlights ongoing sales momentum and improving profitability, supported by reaffirmed long-term targets for compounded annual revenue growth through 2027. We’ll now explore how the raised 2025 revenue outlook could influence Exact Sciences'...

In recent weeks, Vertex Pharmaceuticals reported strong second-quarter financial results with US$2.96 billion in revenue and announced its investigational pain therapy VX-993 did not meet the primary endpoint in a Phase 2 trial, resulting in the decision not to pursue it further as a monotherapy for acute pain. This combination of a pipeline setback and robust financial performance, alongside continued share repurchases and confirmation of annual revenue guidance, reflects both the strengths...

Earlier this week, Chevron U.S.A. Inc., a subsidiary of Chevron Corporation, issued US$5.5 billion in notes with maturities ranging from 2027 to 2035 to secure long-term funding, with the notes guaranteed by its parent company. This financing move coincides with Chevron's focus on production expansion in the Permian Basin and commitment to efficiency and sustainability initiatives. We'll explore how Chevron's US$5.5 billion debt raise could bolster investment in its Permian Basin operations...

Qiagen N.V. recently reported its second quarter and first half 2025 results, with sales of US$533.54 million for the quarter and a return to profitability, compared to a net loss a year earlier. In addition to improved financial performance, the company raised its full-year 2025 outlook for both net sales and core sales growth, signaling growing confidence in operational execution and underlying demand. We will now explore how Qiagen's upgraded guidance and return to profitability may...

Earlier this month, Surgery Partners reported second-quarter 2025 results with sales rising to US$826.2 million and a significantly lower net loss compared to the previous year, while reaffirming its full-year revenue guidance of US$3.3 billion to US$3.45 billion; the company also announced Wayne S. DeVeydt’s immediate resignation as Executive Chairman and director, appointing Blair E. Hendrix as the new Board Chairman and reducing the Board size to 10 directors. Despite the leadership...

Earlier this month, Realty Income Corporation reported its second quarter 2025 earnings, highlighted by increased revenue to US$1.41 billion but a reduction in net income and a downward revision of its full-year earnings guidance, following higher real estate impairments. Despite these financial headwinds, Realty Income maintained its 662nd consecutive monthly dividend and continues to expand in both the U.S. and European real estate markets, reflecting its commitment to shareholder returns...

Supernus Pharmaceuticals recently reported its second-quarter 2025 earnings, showing year-over-year revenue of US$165.45 million and net income of US$22.5 million, alongside updated full-year guidance reflecting anticipated revenue of US$670 million to US$700 million due to strong first-half results and the Sage acquisition. While quarterly revenue declined slightly from the prior year, improved profitability and the upward revision in annual guidance highlight a significant shift in...

Arcellx, Inc. recently reported its second quarter 2025 earnings, disclosing a net loss of US$52.77 million, up from US$27.2 million in the same period last year, and a basic loss per share of US$0.94 versus US$0.51 year-over-year. This sharp increase in net loss highlights considerable changes in the company's cost structure or spending priorities compared to previous periods. We'll examine how Arcellx's significantly higher net losses this quarter influence its investment narrative and...

Howard Hughes Holdings Inc. recently reported its second quarter 2025 results, revealing revenue of US$260.88 million, a decline from US$283.47 million in the prior year, alongside a net loss of US$12.14 million compared to net income of US$21.09 million a year earlier. The shift from profit to loss, despite higher sales for both the quarter and six-month period, raises questions about underlying cost pressures and profitability trends for the company. We'll explore how the swing to a net...

ZoomInfo Technologies recently reported improved second quarter results with US$306.7 million in sales, returning to profitability and raising full-year revenue guidance to a range of US$1.215–1.225 billion, up from prior expectations. Along with completing a major share repurchase and appointing Michael Graham O’Brien as Chief Financial Officer, these developments highlight management’s confidence and a focus on operational discipline. We'll explore how the upgraded revenue outlook and...

Cigna Group recently presented at the 7th Annual Ai4 2025 conference in Las Vegas, with Dan Mackey speaking on the company’s advancements in artificial intelligence and healthcare innovation. A key insight is that regulatory developments indicating potential easing of Medicare Advantage bonus payment requirements have contributed to renewed analyst optimism and sector momentum for health insurers like Cigna. We'll explore how the prospect of less stringent Medicare Advantage bonus rules...

The Kroger Co. recently announced it has reached a confidential settlement with C&S Wholesale Grocers, LLC, resolving all claims in their previously pending litigation before the Superior Court for the State of Delaware. This settlement closes a chapter of legal uncertainty for Kroger, potentially clearing the way for clearer operational and financial planning moving forward. Let's explore how resolving this significant legal dispute may influence Kroger's investment narrative and outlook...

WeRide recently secured regulatory approval to conduct late-night Robotaxi testing on public roads in Beijing, allowing operations from 10pm to 7am as part of its drive toward a 24/7 autonomous ride-hailing network. This milestone showcases WeRide's technological strengths in addressing complex, real-world challenges like low-light and harsh weather, strengthening its position in autonomous mobility innovation. We'll look at how WeRide's expanded Robotaxi testing in Beijing reinforces its...

In August 2025, Rosen Law Firm began investigating potential securities claims against GeneDx Holdings Corp. following allegations that the company issued misleading business information and was accused of fraudulent revenue inflation involving Medicaid and Medicare systems. This legal scrutiny and preparation for a class action lawsuit highlight serious questions about GeneDx’s financial reporting practices and increase the company's exposure to legal and reputational risk. We’ll examine...

Urban Edge Properties recently completed a follow-on equity offering totaling US$250 million and filed a shelf registration to enable the issuance of additional securities, including common and preferred shares as well as debt instruments. This move greatly enhances the company’s financial flexibility, equipping it with fresh capital for future acquisitions, development projects, or potential debt reduction initiatives. We'll examine how the expanded capital base from the equity offering...

Charles River Laboratories International recently announced its second quarter 2025 results, reporting revenue of US$1.03 billion and net income of US$52.33 million, both nearly flat or lower compared to the previous year, and updated its full-year outlook to reflect a smaller projected revenue decline. The company’s revised guidance, showing a softer fall in revenue and confirmation of earnings estimates, may indicate some stabilization in business conditions despite ongoing margin...

Cardinal Health (CAH) recently affirmed its quarterly dividend of $0.51 per share, set for mid-October 2025, underscoring its commitment to shareholder returns. However, the company's stock experienced a 3% decline over the past quarter, contrasting with the broader market which climbed 1% over the last week and 17% over the past year. Despite reporting an increase in net income and earnings per share for the year ending June 2025, Cardinal Health's share price movement was slightly out of...

NasdaqGM:LNTH 1 Year Share Price vs Fair Value Explore Lantheus Holdings's Fair Values from the Community and select...

CSP ( NASDAQ:CSPI ) Third Quarter 2025 Results Key Financial Results Revenue: US$15.4m (up 18% from 3Q 2024). Net loss...

INVO Fertility ( NASDAQ:IVF ) Second Quarter 2025 Results Key Financial Results Net loss: US$3.21m (flat on 2Q 2024...